Herpes zoster with progression to acute varicella zoster virus-meningoencephalitis

International Journal of Dermatology

Volumn 48, Issue 8, 2009, Pages 834-839

  Braun Falco, Markus ^a   Hoffmann, Marco ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTICONVULSIVE AGENT; DIPYRONE; GLUCOCORTICOID; NEUROLEPTIC AGENT; PREDNISONE; PREGABALIN; TRAMADOL; VALACICLOVIR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HERPES ZOSTER; HOSPITALIZATION; HUMAN; MENINGISM; MENINGOENCEPHALITIS; OPHTHALMIC NERVE; PAIN; RISK FACTOR; SOMNOLENCE; SYMPTOM; TREATMENT DURATION; TRIGEMINAL NERVE; VARICELLA ZOSTER VIRUS;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; CONSCIOUSNESS DISORDERS; DISEASE PROGRESSION; ENCEPHALITIS, VARICELLA ZOSTER; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; MALE; MAXILLARY NERVE; MIDDLE AGED; OPHTHALMIC NERVE; RISK FACTORS; SPINAL NERVES; TRIGEMINAL NERVE DISEASES;

EID: 67949097536     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.04023.x     Document Type: Article

References (17)

1. Dworkin RH, Johnson RW, Breuer J, et al. Recommendations for the management of herpes zoster. Clin Infect Dis 2007; 44: S1-S26.
2. Weinberg JM. Herpes zoster: Epidemiology, natural history, and common complications. J Am Acad Dermatol 2007; 57: S130-S135.
3. Insinga RP, Itzler RF, Pellissier JM, et al. The incidence of herpes zoster in a United States Administrative Database. J Gen Intern Med 2005; 20: 748-753.
4. Steiner I, Kennedy PGE, Pachner AR. The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol 2007; 6: 1015-1028.
5. Volpi A. Severe complications of herpes zoster. Herpes 2007; 14 (Suppl. 2): 35-39.
6. Gilden DH. Varicella zoster virus and central nervous system syndromes. Herpes 2004; 11: S89A-S94A.
7. Gnann JW Jr. Varicella-zoster virus: Atypical presentation and unusual complication. J Infect Dis 2002; 186: S91-S98.
8. Gross G, Schöfer H, Wassilew S, et al. Herpes zoster guidelines of the German Dermatology Society (DDG). J Clin Virol 2003; 26: 277-289.
9. Jemsek J, Greenberg SB, Taber L, et al. Herpes zoster-associated encephalitis: Clinicopathologic report of 12 cases and review of the literature. Medicine 1983; 62: 81-97.
10. Studahl M, Hagberg L, Rekabdar E, et al. Herpesvirus DNA detection in cerebral spinal fluid: Differences in clinical presentation between alpha-, beta-, and gamma-herpesviruses. Scand J Infect Dis 2000; 32: 237-248.
11. Sánchez-Guerra M, Infante J, Pascual J, et al. Neurologic complications of herpes zoster. A retrospective study in 100 patients. Neurologia 2001; 16: 112-117.
12. Schmader K. Herpes zoster in older adults. Clin Infect Dis 2001; 32: 1481-1486.
13. Levin MJ, Smith JG, Kaufhold RM, et al. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis 2003; 188: 1336-1344.
14. Arvin A. Aging, immunity, and the varicella-zoster virus. N Engl J Med 2005; 352: 2266-2267.
15. Whitley RJ, Weiss H, Gnann JW Jr, et al. Acyclovir with and without prednisone for the treatment of herpes zoster: A randomized, placebo-controlled trial. Ann Intern Med 1996; 125: 376-383.
16. Oxman MN, Levin MJ and the Shingles Prevention Study Group. Vaccination against herpes zoster and postherpetic neuralgia. J Infect Dis 2008; 197 (Suppl. 2): S228-S236.
17. Oxman MN, Levin MJ and the Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352: 2271-2284.